BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

608 related articles for article (PubMed ID: 28292019)

  • 1. Carcinogenesis mechanisms of Fusobacterium nucleatum.
    Gholizadeh P; Eslami H; Kafil HS
    Biomed Pharmacother; 2017 May; 89():918-925. PubMed ID: 28292019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fusobacterium nucleatum and colorectal cancer: A mechanistic overview.
    Hashemi Goradel N; Heidarzadeh S; Jahangiri S; Farhood B; Mortezaee K; Khanlarkhani N; Negahdari B
    J Cell Physiol; 2019 Mar; 234(3):2337-2344. PubMed ID: 30191984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Fusobacterium nucleatum with immunity and molecular alterations in colorectal cancer.
    Nosho K; Sukawa Y; Adachi Y; Ito M; Mitsuhashi K; Kurihara H; Kanno S; Yamamoto I; Ishigami K; Igarashi H; Maruyama R; Imai K; Yamamoto H; Shinomura Y
    World J Gastroenterol; 2016 Jan; 22(2):557-66. PubMed ID: 26811607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomic characterization of outer membrane vesicles from gut mucosa-derived fusobacterium nucleatum.
    Liu J; Hsieh CL; Gelincik O; Devolder B; Sei S; Zhang S; Lipkin SM; Chang YF
    J Proteomics; 2019 Mar; 195():125-137. PubMed ID: 30634002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fusobacterium nucleatum and oral cancer: a critical review.
    McIlvanna E; Linden GJ; Craig SG; Lundy FT; James JA
    BMC Cancer; 2021 Nov; 21(1):1212. PubMed ID: 34774023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fusobacterium nucleatum, a key pathogenic factor and microbial biomarker for colorectal cancer.
    Wang N; Fang JY
    Trends Microbiol; 2023 Feb; 31(2):159-172. PubMed ID: 36058786
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Ye X; Wang R; Bhattacharya R; Boulbes DR; Fan F; Xia L; Adoni H; Ajami NJ; Wong MC; Smith DP; Petrosino JF; Venable S; Qiao W; Baladandayuthapani V; Maru D; Ellis LM
    Cancer Prev Res (Phila); 2017 Jul; 10(7):398-409. PubMed ID: 28483840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FadA promotes DNA damage and progression of Fusobacterium nucleatum-induced colorectal cancer through up-regulation of chk2.
    Guo P; Tian Z; Kong X; Yang L; Shan X; Dong B; Ding X; Jing X; Jiang C; Jiang N; Yu Y
    J Exp Clin Cancer Res; 2020 Sep; 39(1):202. PubMed ID: 32993749
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Hussan H; Clinton SK; Roberts K; Bailey MT
    World J Gastroenterol; 2017 Dec; 23(48):8626-8650. PubMed ID: 29358871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of
    Sun CH; Li BB; Wang B; Zhao J; Zhang XY; Li TT; Li WB; Tang D; Qiu MJ; Wang XC; Zhu CM; Qian ZR
    Chronic Dis Transl Med; 2019 Sep; 5(3):178-187. PubMed ID: 31891129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fusobacterium nucleatum: an emerging bug in colorectal tumorigenesis.
    Bashir A; Miskeen AY; Bhat A; Fazili KM; Ganai BA
    Eur J Cancer Prev; 2015 Sep; 24(5):373-85. PubMed ID: 25569450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of
    Pignatelli P; Nuccio F; Piattelli A; Curia MC
    Microorganisms; 2023 Sep; 11(9):. PubMed ID: 37764202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/β-catenin signaling via its FadA adhesin.
    Rubinstein MR; Wang X; Liu W; Hao Y; Cai G; Han YW
    Cell Host Microbe; 2013 Aug; 14(2):195-206. PubMed ID: 23954158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ways Fusobacterium nucleatum translocate to breast tissue and contribute to breast cancer development.
    Guo X; Yu K; Huang R
    Mol Oral Microbiol; 2024 Feb; 39(1):1-11. PubMed ID: 38171827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fusobacterium nucleatum - Friend or foe?
    Stokowa-Sołtys K; Wojtkowiak K; Jagiełło K
    J Inorg Biochem; 2021 Nov; 224():111586. PubMed ID: 34425476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and characterization of a novel adhesin unique to oral fusobacteria.
    Han YW; Ikegami A; Rajanna C; Kawsar HI; Zhou Y; Li M; Sojar HT; Genco RJ; Kuramitsu HK; Deng CX
    J Bacteriol; 2005 Aug; 187(15):5330-40. PubMed ID: 16030227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fusobacterium nucleatum and T Cells in Colorectal Carcinoma.
    Mima K; Sukawa Y; Nishihara R; Qian ZR; Yamauchi M; Inamura K; Kim SA; Masuda A; Nowak JA; Nosho K; Kostic AD; Giannakis M; Watanabe H; Bullman S; Milner DA; Harris CC; Giovannucci E; Garraway LA; Freeman GJ; Dranoff G; Chan AT; Garrett WS; Huttenhower C; Fuchs CS; Ogino S
    JAMA Oncol; 2015 Aug; 1(5):653-61. PubMed ID: 26181352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fusobacterium nucleatum - symbiont, opportunist and oncobacterium.
    Brennan CA; Garrett WS
    Nat Rev Microbiol; 2019 Mar; 17(3):156-166. PubMed ID: 30546113
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Casasanta MA; Yoo CC; Udayasuryan B; Sanders BE; Umaña A; Zhang Y; Peng H; Duncan AJ; Wang Y; Li L; Verbridge SS; Slade DJ
    Sci Signal; 2020 Jul; 13(641):. PubMed ID: 32694172
    [No Abstract]   [Full Text] [Related]  

  • 20. Fusobacterium nucleatum in tumors: from tumorigenesis to tumor metastasis and tumor resistance.
    Ye C; Liu X; Liu Z; Pan C; Zhang X; Zhao Z; Sun H
    Cancer Biol Ther; 2024 Dec; 25(1):2306676. PubMed ID: 38289287
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 31.